Leap therapeutics to participate at piper sandler 35th annual healthcare conference

Cambridge, mass. , nov. 21, 2023 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that douglas e.

LPTX Ratings Summary

LPTX Quant Ranking